Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report
An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infectio...
Gespeichert in:
Veröffentlicht in: | American journal of transplantation 2020-07, Vol.20 (7), p.1864-1868 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1868 |
---|---|
container_issue | 7 |
container_start_page | 1864 |
container_title | American journal of transplantation |
container_volume | 20 |
creator | Ning, Ling Liu, Lei Li, Wenyuan Liu, Hongtao Wang, Jizhou Yao, Ziqin Zhang, Shengyu Zhao, Desheng Nashan, Björn Shen, Aizong Liu, Lianxin Li, Lei |
description | An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failure, and no pharmacological therapies of proven efficacy yet exist. We report a case of SARS‐CoV‐2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of cyclosporine in patients treated with lopinavir/ritonavir; the routine treatment of corticosteroid can be continued. This is a rare report of SARS‐CoV‐2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity, and outcome of SARS‐CoV‐2 infections in solid organ transplant recipients.
Routine treatment of immunosuppression and individualized antiviral therapy were implemented in a case of SARS‐CoV‐2 infection in a renal transplant recipient, with an excellent outcome. |
doi_str_mv | 10.1111/ajt.15897 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7262121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417953342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3707-2f7d734b1691d4b035e495192ee3211cfbaa474961a502bd64938cf704d211fc3</originalsourceid><addsrcrecordid>eNp1kctKAzEUhoMoVqsLX0AG3NhF21wnHRdCKV4pCrYKrkImk9GU6WRMppXufASf0Scx2lp0YRYnJzkff87JD8ABgh0UVldO6g5ivYRvgB0UQ9iOESWb65ywBtj1fgIh4riHt0GDYMw5Y2wHPN7YuS4iZZ0t5dy4mY-OR_270cfb-8A-hIhbkSlzrWpjy5BFMnK6lEVUO1n6qpBlHS6UqYwu65NoIL0O58q6eg9s5bLwen-1N8H9-dl4cNke3l5cDfrDtiIc8jbOecYJTVGcoIymkDBNE4YSrDXBCKk8lZJymsRIMojTLKYJ6amcQ5qFcq5IE5wudatZOtWZCn04WYjKmal0C2GlEX8rpXkWT3YuOI4xwigIHK0EnH2ZaV-LiZ25MKMXmCKeMEIoDlRrSSlnvXc6X7-AoPhyQQQXxLcLgT383dKa_Pn2AHSXwKsp9OJ_JdG_Hi8lPwHg-ZKy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417953342</pqid></control><display><type>article</type><title>Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report</title><source>MEDLINE</source><source>Wiley Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ning, Ling ; Liu, Lei ; Li, Wenyuan ; Liu, Hongtao ; Wang, Jizhou ; Yao, Ziqin ; Zhang, Shengyu ; Zhao, Desheng ; Nashan, Björn ; Shen, Aizong ; Liu, Lianxin ; Li, Lei</creator><creatorcontrib>Ning, Ling ; Liu, Lei ; Li, Wenyuan ; Liu, Hongtao ; Wang, Jizhou ; Yao, Ziqin ; Zhang, Shengyu ; Zhao, Desheng ; Nashan, Björn ; Shen, Aizong ; Liu, Lianxin ; Li, Lei</creatorcontrib><description>An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failure, and no pharmacological therapies of proven efficacy yet exist. We report a case of SARS‐CoV‐2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of cyclosporine in patients treated with lopinavir/ritonavir; the routine treatment of corticosteroid can be continued. This is a rare report of SARS‐CoV‐2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity, and outcome of SARS‐CoV‐2 infections in solid organ transplant recipients.
Routine treatment of immunosuppression and individualized antiviral therapy were implemented in a case of SARS‐CoV‐2 infection in a renal transplant recipient, with an excellent outcome.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/ajt.15897</identifier><identifier>PMID: 32277555</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Adrenal Cortex Hormones - administration & dosage ; Adult ; Antiretroviral drugs ; Antiviral drugs ; Asymptomatic infection ; Betacoronavirus ; Case Report ; Case Reports ; China - epidemiology ; Clinical decision making ; clinical research/practice ; Coronaviridae ; Coronavirus Infections - complications ; Coronavirus Infections - diagnosis ; Coronavirus Infections - therapy ; Coronaviruses ; Corticosteroids ; COVID-19 ; Cyclosporine - administration & dosage ; Cyclosporine - blood ; Cyclosporins ; Disease Outbreaks ; Drug Combinations ; Health risk assessment ; Humans ; Immunosuppression Therapy - adverse effects ; Immunosuppressive agents ; Immunosuppressive Agents - administration & dosage ; immunosuppressive regimens‐maintenance ; infection and infectious agents‐viral ; Infections ; infectious disease ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - surgery ; Kidney Transplantation ; kidney transplantation/nephrology ; Kidney transplants ; Living Donors ; Lopinavir ; Lopinavir - administration & dosage ; Male ; Pandemics ; Patients ; Pneumonia, Viral - complications ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - therapy ; Renal failure ; Respiratory distress syndrome ; Reverse Transcriptase Polymerase Chain Reaction ; Ritonavir ; Ritonavir - administration & dosage ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Tomography, X-Ray Computed ; Transplant Recipients ; Treatment Outcome</subject><ispartof>American journal of transplantation, 2020-07, Vol.20 (7), p.1864-1868</ispartof><rights>2020 The American Society of Transplantation and the American Society of Transplant Surgeons</rights><rights>2020 The American Society of Transplantation and the American Society of Transplant Surgeons.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3707-2f7d734b1691d4b035e495192ee3211cfbaa474961a502bd64938cf704d211fc3</cites><orcidid>0000-0002-7307-9827</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajt.15897$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajt.15897$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32277555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ning, Ling</creatorcontrib><creatorcontrib>Liu, Lei</creatorcontrib><creatorcontrib>Li, Wenyuan</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><creatorcontrib>Wang, Jizhou</creatorcontrib><creatorcontrib>Yao, Ziqin</creatorcontrib><creatorcontrib>Zhang, Shengyu</creatorcontrib><creatorcontrib>Zhao, Desheng</creatorcontrib><creatorcontrib>Nashan, Björn</creatorcontrib><creatorcontrib>Shen, Aizong</creatorcontrib><creatorcontrib>Liu, Lianxin</creatorcontrib><creatorcontrib>Li, Lei</creatorcontrib><title>Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failure, and no pharmacological therapies of proven efficacy yet exist. We report a case of SARS‐CoV‐2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of cyclosporine in patients treated with lopinavir/ritonavir; the routine treatment of corticosteroid can be continued. This is a rare report of SARS‐CoV‐2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity, and outcome of SARS‐CoV‐2 infections in solid organ transplant recipients.
Routine treatment of immunosuppression and individualized antiviral therapy were implemented in a case of SARS‐CoV‐2 infection in a renal transplant recipient, with an excellent outcome.</description><subject>Adrenal Cortex Hormones - administration & dosage</subject><subject>Adult</subject><subject>Antiretroviral drugs</subject><subject>Antiviral drugs</subject><subject>Asymptomatic infection</subject><subject>Betacoronavirus</subject><subject>Case Report</subject><subject>Case Reports</subject><subject>China - epidemiology</subject><subject>Clinical decision making</subject><subject>clinical research/practice</subject><subject>Coronaviridae</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - therapy</subject><subject>Coronaviruses</subject><subject>Corticosteroids</subject><subject>COVID-19</subject><subject>Cyclosporine - administration & dosage</subject><subject>Cyclosporine - blood</subject><subject>Cyclosporins</subject><subject>Disease Outbreaks</subject><subject>Drug Combinations</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Immunosuppression Therapy - adverse effects</subject><subject>Immunosuppressive agents</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>immunosuppressive regimens‐maintenance</subject><subject>infection and infectious agents‐viral</subject><subject>Infections</subject><subject>infectious disease</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - surgery</subject><subject>Kidney Transplantation</subject><subject>kidney transplantation/nephrology</subject><subject>Kidney transplants</subject><subject>Living Donors</subject><subject>Lopinavir</subject><subject>Lopinavir - administration & dosage</subject><subject>Male</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - therapy</subject><subject>Renal failure</subject><subject>Respiratory distress syndrome</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ritonavir</subject><subject>Ritonavir - administration & dosage</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tomography, X-Ray Computed</subject><subject>Transplant Recipients</subject><subject>Treatment Outcome</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKAzEUhoMoVqsLX0AG3NhF21wnHRdCKV4pCrYKrkImk9GU6WRMppXufASf0Scx2lp0YRYnJzkff87JD8ABgh0UVldO6g5ivYRvgB0UQ9iOESWb65ywBtj1fgIh4riHt0GDYMw5Y2wHPN7YuS4iZZ0t5dy4mY-OR_270cfb-8A-hIhbkSlzrWpjy5BFMnK6lEVUO1n6qpBlHS6UqYwu65NoIL0O58q6eg9s5bLwen-1N8H9-dl4cNke3l5cDfrDtiIc8jbOecYJTVGcoIymkDBNE4YSrDXBCKk8lZJymsRIMojTLKYJ6amcQ5qFcq5IE5wudatZOtWZCn04WYjKmal0C2GlEX8rpXkWT3YuOI4xwigIHK0EnH2ZaV-LiZ25MKMXmCKeMEIoDlRrSSlnvXc6X7-AoPhyQQQXxLcLgT383dKa_Pn2AHSXwKsp9OJ_JdG_Hi8lPwHg-ZKy</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Ning, Ling</creator><creator>Liu, Lei</creator><creator>Li, Wenyuan</creator><creator>Liu, Hongtao</creator><creator>Wang, Jizhou</creator><creator>Yao, Ziqin</creator><creator>Zhang, Shengyu</creator><creator>Zhao, Desheng</creator><creator>Nashan, Björn</creator><creator>Shen, Aizong</creator><creator>Liu, Lianxin</creator><creator>Li, Lei</creator><general>Elsevier Limited</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7307-9827</orcidid></search><sort><creationdate>202007</creationdate><title>Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report</title><author>Ning, Ling ; Liu, Lei ; Li, Wenyuan ; Liu, Hongtao ; Wang, Jizhou ; Yao, Ziqin ; Zhang, Shengyu ; Zhao, Desheng ; Nashan, Björn ; Shen, Aizong ; Liu, Lianxin ; Li, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3707-2f7d734b1691d4b035e495192ee3211cfbaa474961a502bd64938cf704d211fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adrenal Cortex Hormones - administration & dosage</topic><topic>Adult</topic><topic>Antiretroviral drugs</topic><topic>Antiviral drugs</topic><topic>Asymptomatic infection</topic><topic>Betacoronavirus</topic><topic>Case Report</topic><topic>Case Reports</topic><topic>China - epidemiology</topic><topic>Clinical decision making</topic><topic>clinical research/practice</topic><topic>Coronaviridae</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - therapy</topic><topic>Coronaviruses</topic><topic>Corticosteroids</topic><topic>COVID-19</topic><topic>Cyclosporine - administration & dosage</topic><topic>Cyclosporine - blood</topic><topic>Cyclosporins</topic><topic>Disease Outbreaks</topic><topic>Drug Combinations</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Immunosuppression Therapy - adverse effects</topic><topic>Immunosuppressive agents</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>immunosuppressive regimens‐maintenance</topic><topic>infection and infectious agents‐viral</topic><topic>Infections</topic><topic>infectious disease</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - surgery</topic><topic>Kidney Transplantation</topic><topic>kidney transplantation/nephrology</topic><topic>Kidney transplants</topic><topic>Living Donors</topic><topic>Lopinavir</topic><topic>Lopinavir - administration & dosage</topic><topic>Male</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - therapy</topic><topic>Renal failure</topic><topic>Respiratory distress syndrome</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ritonavir</topic><topic>Ritonavir - administration & dosage</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tomography, X-Ray Computed</topic><topic>Transplant Recipients</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ning, Ling</creatorcontrib><creatorcontrib>Liu, Lei</creatorcontrib><creatorcontrib>Li, Wenyuan</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><creatorcontrib>Wang, Jizhou</creatorcontrib><creatorcontrib>Yao, Ziqin</creatorcontrib><creatorcontrib>Zhang, Shengyu</creatorcontrib><creatorcontrib>Zhao, Desheng</creatorcontrib><creatorcontrib>Nashan, Björn</creatorcontrib><creatorcontrib>Shen, Aizong</creatorcontrib><creatorcontrib>Liu, Lianxin</creatorcontrib><creatorcontrib>Li, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ning, Ling</au><au>Liu, Lei</au><au>Li, Wenyuan</au><au>Liu, Hongtao</au><au>Wang, Jizhou</au><au>Yao, Ziqin</au><au>Zhang, Shengyu</au><au>Zhao, Desheng</au><au>Nashan, Björn</au><au>Shen, Aizong</au><au>Liu, Lianxin</au><au>Li, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2020-07</date><risdate>2020</risdate><volume>20</volume><issue>7</issue><spage>1864</spage><epage>1868</epage><pages>1864-1868</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failure, and no pharmacological therapies of proven efficacy yet exist. We report a case of SARS‐CoV‐2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of cyclosporine in patients treated with lopinavir/ritonavir; the routine treatment of corticosteroid can be continued. This is a rare report of SARS‐CoV‐2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity, and outcome of SARS‐CoV‐2 infections in solid organ transplant recipients.
Routine treatment of immunosuppression and individualized antiviral therapy were implemented in a case of SARS‐CoV‐2 infection in a renal transplant recipient, with an excellent outcome.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>32277555</pmid><doi>10.1111/ajt.15897</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-7307-9827</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1600-6135 |
ispartof | American journal of transplantation, 2020-07, Vol.20 (7), p.1864-1868 |
issn | 1600-6135 1600-6143 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7262121 |
source | MEDLINE; Wiley Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adrenal Cortex Hormones - administration & dosage Adult Antiretroviral drugs Antiviral drugs Asymptomatic infection Betacoronavirus Case Report Case Reports China - epidemiology Clinical decision making clinical research/practice Coronaviridae Coronavirus Infections - complications Coronavirus Infections - diagnosis Coronavirus Infections - therapy Coronaviruses Corticosteroids COVID-19 Cyclosporine - administration & dosage Cyclosporine - blood Cyclosporins Disease Outbreaks Drug Combinations Health risk assessment Humans Immunosuppression Therapy - adverse effects Immunosuppressive agents Immunosuppressive Agents - administration & dosage immunosuppressive regimens‐maintenance infection and infectious agents‐viral Infections infectious disease Kidney Failure, Chronic - complications Kidney Failure, Chronic - surgery Kidney Transplantation kidney transplantation/nephrology Kidney transplants Living Donors Lopinavir Lopinavir - administration & dosage Male Pandemics Patients Pneumonia, Viral - complications Pneumonia, Viral - diagnosis Pneumonia, Viral - therapy Renal failure Respiratory distress syndrome Reverse Transcriptase Polymerase Chain Reaction Ritonavir Ritonavir - administration & dosage SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Tomography, X-Ray Computed Transplant Recipients Treatment Outcome |
title | Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: Case report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20coronavirus%20(SARS%E2%80%90CoV%E2%80%902)%20infection%20in%20a%20renal%20transplant%20recipient:%20Case%20report&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Ning,%20Ling&rft.date=2020-07&rft.volume=20&rft.issue=7&rft.spage=1864&rft.epage=1868&rft.pages=1864-1868&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/ajt.15897&rft_dat=%3Cproquest_pubme%3E2417953342%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417953342&rft_id=info:pmid/32277555&rfr_iscdi=true |